Docetaxel (taxotere) for the treatment of anthracycline resistant breast cancer

Seminars in Oncology

Volumn 24, Issue 4 SUPPL. 10, 1997, Pages

  Ravdin, P M ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRACYCLINE DERIVATIVE; DOCETAXEL; DOXORUBICIN; PACLITAXEL;

ANTINEOPLASTIC ACTIVITY; BREAST CANCER; CANCER CHEMOTHERAPY; DRUG EFFICACY; HUMAN; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; REVIEW;

ANTHRACYCLINES; ANTINEOPLASTIC AGENTS, PHYTOGENIC; BREAST NEOPLASMS; DRUG RESISTANCE, NEOPLASM; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; PACLITAXEL; TAXOIDS; TREATMENT OUTCOME;

EID: 18544398495     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (26)